SCHEMBL7484204

SCHEMBL7484204

CN1CCN(CCc2nc3c([N+](=O)[O-])cccc3[nH]2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 2/20 0.45
PKN1 Q16512 1/20 0.44
PKN2 Q16513 1/20 0.44
HRH4 Q9H3N8 2/20 0.44
ITGB3 P05106 1/20 0.44
ITGAV P06756 1/20 0.44
HTR6 P50406 2/20 0.43
HTT P42858 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
CYP3A4 P08684 1/20 0.41
ABCC1 P33527 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
CHRNA7 P36544 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7470721 0.89 DRD4 (0.56) DRD4PKN1PKN2HRH4ITGB3
SCHEMBL1892570 0.80 KDM4E (0.52) DRD4PKN1PKN2ITGB3ITGAV
SCHEMBL7481575 0.79 HTR6 (0.47) DRD4HRH4ITGB3ITGAVHTR6
SCHEMBL6117926 0.78 PKN1 (0.48) PKN1PKN2HRH4HTR6HTT
SCHEMBL7473327 0.78 DRD4 (0.57) DRD4PKN1PKN2HTTADORA3
SCHEMBL5331503 0.78 HRH3 (0.41) DRD4PKN1PKN2ITGB3ITGAV
SCHEMBL7479338 0.77 PKN1 (0.52) DRD4PKN1PKN2CYP3A4ADORA3
SCHEMBL7476376 0.77 DRD4 (0.56) DRD4PKN1PKN2HTTADORA3
SCHEMBL8598342 0.77 GAA (0.56) DRD4PKN1PKN2ITGB3ITGAV
SCHEMBL7479144 0.77 GAA (0.46) PKN1PKN2HTR6HTTADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed